NASH - NONALCOHOLIC STEATOHEPATITIS
Clinical trials for NASH - NONALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NASH - NONALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NASH - NONALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection shows promise in reversing dangerous liver scarring
Disease control CompletedThis study tested whether a new drug called BIO89-100 could help people with a serious fatty liver disease called NASH. 222 adults with confirmed liver scarring received either the drug or a placebo injection weekly for 24 weeks. Researchers checked if the treatment could reduce …
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: 89bio, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Could a growth hormone booster shrink dangerous liver fat?
Disease control CompletedThis small pilot study tested whether a drug called ibutamoren could reduce fat buildup in the livers of people with nonalcoholic fatty liver disease (NAFLD). Researchers enrolled 12 generally healthy adults with NAFLD to take the drug for 6 months. The main goal was to see if li…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New test could replace painful liver biopsies for millions
Diagnosis CompletedThis study tested a new, non-invasive blood test called the LLIFT to see if it could accurately diagnose fatty liver disease (NAFLD) and its more severe form (NASH). It involved 158 people at high risk for metabolic problems like obesity and diabetes. The goal was to find a simpl…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Sponsor: University Hospital, Lille • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Breakthrough scan lets kids breathe easy during liver tests
Diagnosis CompletedThis study tested new MRI scanning technology designed specifically for children. Current liver scans require patients to hold their breath, which is very difficult for kids and infants. The research aimed to develop 'free-breathing' MRI methods to make liver disease diagnosis mo…
Matched conditions: NASH - NONALCOHOLIC STEATOHEPATITIS
Sponsor: University of California, Los Angeles • Aim: Diagnosis
Last updated Mar 20, 2026 14:47 UTC